| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |